openPR Logo
Press release

Global Genotyping Market Size Worth USD 38.7 Billion By 2030 | CAGR 12.5%: Infinium Global Research

Global Genotyping Market Size Worth USD 38.7 Billion By 2030 |

Infinium Global Research announces the release of an extensive report delving into the Genotyping Market, providing a profound analysis of segments, sub-segments, and the significant impact of drivers, restraints, and macro indicators on the global and regional Genotyping Market. The report offers a comprehensive depiction of trends, forecasts, and monetary valuations within the global Genotyping Market landscape.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1233

Market Overview and Projections

The Genotyping Market, valued at USD 13.3 billion in 2022, is anticipated to surge to USD 38.7 billion by 2030, exhibiting a robust Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period from 2023 to 2030.

Unlocking the Genetic Code: Advancements in Genotyping

Genotyping involves the analysis of an individual's genetic material, such as DNA, to identify specific genetic variations or markers. Utilizing techniques like PCR, DNA sequencing, and microarray analysis, it assists in determining an individual's genetic makeup, offering insights into disease predisposition, medication response, ancestry, and trait associations. The applications span across medicine, genetics research, agriculture, forensics, and population genetics, enabling breakthroughs in disease understanding, targeted therapies, and agricultural advancements.

Drivers and Contributions to Market Growth

The rising incidence of genetic diseases like cancer, diabetes, and tuberculosis significantly propels the genotyping market forward. Genotyping plays a pivotal role in comprehending the genetic factors associated with these diseases, leading to enhanced disease management, personalized treatments, and precise interventions. Moreover, its crucial role in the pharmaceutical industry, fostering the need for more effective treatments and personalized medicine, continues to drive market growth, prompting increased research and development in the sector.

Challenges and Technological Advancements

While stringent regulations and unfavorable reimbursement practices pose limitations, technological advancements in genotyping, especially through DNA microarray technology, promise significant market growth. The deployment of advanced genotyping technologies enhances resolution and accuracy, revolutionizing the field.

Regional Dynamics and Market Segments

North America is poised to dominate the Genotyping Market, supported by advanced healthcare infrastructure, robust R&D activities, and increased adoption of personalized medicine. Conversely, the Asia Pacific region emerges as the fastest-growing market, driven by a burgeoning population and a rising prevalence of genetic diseases, amplifying the need for genotyping technologies.

Detailed Segments Covered in the Report

The report segments the global Genotyping Market based on product (instruments, reagents & kits, bioinformatics, software, and services), technology (PCR, microarrays, sequencing, etc.), application (pharmacogenomics, diagnostics, personalized medicine, etc.), and end-use (pharmaceutical companies, diagnostics labs, academic institutes, etc.).

Profiles of Key Market Players

The report encompasses detailed profiles of industry leaders such as Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Fluidigm (now Standard BioTools), Danaher, Agilent Technologies, Inc., Eurofins Scientific, GE HealthCare, and BGI Group, shedding light on their strategies and market positioning.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1233

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Genotyping Market Highlights

2.2. Genotyping Market Projection

2.3. Genotyping Market Regional Highlights

Chapter 3. Global Genotyping Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Product

3.4.2. IGR-Growth Matrix Analysis by Technology

3.4.3. IGR-Growth Matrix Analysis by Application

3.4.4. IGR-Growth Matrix Analysis by End-use

3.4.5. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Genotyping Market

Chapter 4. Genotyping Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Genotyping Market

5.2. Companies Profiles

5.2.1. Illumina, Inc.

5.2.2. Thermo Fisher Scientific Inc.

5.2.3. QIAGEN

5.2.4. F. Hoffmann-La Roche Ltd

5.2.5. Fluidigm (is now Standard BioTools)

5.2.6. Danaher

5.2.7. Agilent Technologies, Inc.

5.2.8. Eurofins Scientific

5.2.9. GE HealthCare

5.2.10. BGI Group

Chapter 6. Global Genotyping Market by Product

6.1. Instruments

6.2. Reagents & Kits

6.3. Bioinformatics

6.4. Software and Services

Chapter 7. Global Genotyping Market by Technology

7.1. PCR

7.2. Capillary Electrophoresis

7.3. Microarrays

7.4. MALDI-TOF

7.5. Sequencing

7.6. Mass Spectrometry

7.7. Others

Chapter 8. Global Genotyping Market by Application

8.1. Pharmacogenomics

8.2. Diagnostics

8.3. Personalized Medicine

8.4. Agricultural Biotechnology

8.5. Animal Genetic

8.6. Others

Chapter 9. Global Genotyping Market by End-use

9.1. Pharmaceutical and Biopharmaceutical Companies

9.2. Diagnostics and Research Laboratories

9.3. Academic Institutes

9.4. Others

Chapter 10. Global Genotyping Market by Region 2023-2030

10.1. North America

10.1.1. North America Genotyping Market by Product

10.1.2. North America Genotyping Market by Technology

10.1.3. North America Genotyping Market by Application

10.1.4. North America Genotyping Market by End-use

10.1.5. North America Genotyping Market by Country

10.1.5.1. The U.S. Genotyping Market

10.1.5.1.1. The U.S. Genotyping Market by Product

10.1.5.1.2. The U.S. Genotyping Market by Technology

10.1.5.1.3. The U.S. Genotyping Market by Application

10.1.5.1.4. The U.S. Genotyping Market by End-use

10.1.5.2. Canada Genotyping Market

10.1.5.2.1. Canada Genotyping Market by Product

10.1.5.2.2. Canada Genotyping Market by Technology

10.1.5.2.3. Canada Genotyping Market by Application

10.1.5.2.4. Canada Genotyping Market by End-use

10.1.5.3. Mexico Genotyping Market

10.1.5.3.1. Mexico Genotyping Market by Product

10.1.5.3.2. Mexico Genotyping Market by Technology

10.1.5.3.3. Mexico Genotyping Market by Application

10.1.5.3.4. Mexico Genotyping Market by End-use

10.2. Europe

10.2.1. Europe Genotyping Market by Product

10.2.2. Europe Genotyping Market by Technology

10.2.3. Europe Genotyping Market by Application

10.2.4. Europe Genotyping Market by End-use

10.2.5. Europe Genotyping Market by Country

10.2.5.1. Germany Genotyping Market

10.2.5.1.1. Germany Genotyping Market by Product

10.2.5.1.2. Germany Genotyping Market by Technology

10.2.5.1.3. Germany Genotyping Market by Application

10.2.5.1.4. Germany Genotyping Market by End-use

10.2.5.2. United Kingdom Genotyping Market

10.2.5.2.1. United Kingdom Genotyping Market by Product

10.2.5.2.2. United Kingdom Genotyping Market by Technology

10.2.5.2.3. United Kingdom Genotyping Market by Application

10.2.5.2.4. United Kingdom Genotyping Market by End-use

10.2.5.3. France Genotyping Market

10.2.5.3.1. France Genotyping Market by Product

10.2.5.3.2. France Genotyping Market by Technology

10.2.5.3.3. France Genotyping Market by Application

10.2.5.3.4. France Genotyping Market by End-use

10.2.5.4. Italy Genotyping Market

10.2.5.4.1. Italy Genotyping Market by Product

10.2.5.4.2. Italy Genotyping Market by Technology

10.2.5.4.3. Italy Genotyping Market by Application

10.2.5.4.4. Italy Genotyping Market by End-use

10.2.5.5. Rest of Europe Genotyping Market

10.2.5.5.1. Rest of Europe Genotyping Market by Product

10.2.5.5.2. Rest of Europe Genotyping Market by Technology

10.2.5.5.3. Rest of Europe Genotyping Market by Application

10.2.5.5.4. Rest of Europe Genotyping Market by End-use

10.3. Asia Pacific

10.3.1. Asia Pacific Genotyping Market by Product

10.3.2. Asia Pacific Genotyping Market by Technology

10.3.3. Asia Pacific Genotyping Market by Application

10.3.4. Asia Pacific Genotyping Market by End-use

10.3.5. Asia Pacific Genotyping Market by Country

10.3.5.1. China Genotyping Market

10.3.5.1.1. China Genotyping Market by Product

10.3.5.1.2. China Genotyping Market by Technology

10.3.5.1.3. China Genotyping Market by Application

10.3.5.1.4. China Genotyping Market by End-use

10.3.5.2. Japan Genotyping Market

10.3.5.2.1. Japan Genotyping Market by Product

10.3.5.2.2. Japan Genotyping Market by Technology

10.3.5.2.3. Japan Genotyping Market by Application

10.3.5.2.4. Japan Genotyping Market by End-use

10.3.5.3. India Genotyping Market

10.3.5.3.1. India Genotyping Market by Product

10.3.5.3.2. India Genotyping Market by Technology

10.3.5.3.3. India Genotyping Market by Application

10.3.5.3.4. India Genotyping Market by End-use

10.3.5.4. South Korea Genotyping Market

10.3.5.4.1. South Korea Genotyping Market by Product

10.3.5.4.2. South Korea Genotyping Market by Technology

10.3.5.4.3. South Korea Genotyping Market by Application

10.3.5.4.4. South Korea Genotyping Market by End-use

10.3.5.5. Australia Genotyping Market

10.3.5.5.1. Australia Genotyping Market by Product

10.3.5.5.2. Australia Genotyping Market by Technology

10.3.5.5.3. Australia Genotyping Market by Application

10.3.5.5.4. Australia Genotyping Market by End-use

10.3.5.6. Rest of Asia-Pacific Genotyping Market

10.3.5.6.1. Rest of Asia-Pacific Genotyping Market by Product

10.3.5.6.2. Rest of Asia-Pacific Genotyping Market by Technology

10.3.5.6.3. Rest of Asia-Pacific Genotyping Market by Application

10.3.5.6.4. Rest of Asia-Pacific Genotyping Market by End-use

10.4. RoW

10.4.1. RoW Genotyping Market by Product

10.4.2. RoW Genotyping Market by Technology

10.4.3. RoW Genotyping Market by Application

10.4.4. RoW Genotyping Market by End-use

10.4.5. RoW Genotyping Market by Sub-region

10.4.5.1. Latin America Genotyping Market

10.4.5.1.1. Latin America Genotyping Market by Product

10.4.5.1.2. Latin America Genotyping Market by Technology

10.4.5.1.3. Latin America Genotyping Market by Application

10.4.5.1.4. Latin America Genotyping Market by End-use

10.4.5.2. Middle East Genotyping Market

10.4.5.2.1. Middle East Genotyping Market by Product

10.4.5.2.2. Middle East Genotyping Market by Technology

10.4.5.2.3. Middle East Genotyping Market by Application

10.4.5.2.4. Middle East Genotyping Market by End-use

10.4.5.3. Africa Genotyping Market

10.4.5.3.1. Africa Genotyping Market by Product

10.4.5.3.2. Africa Genotyping Market by Technology

10.4.5.3.3. Africa Genotyping Market by Application

10.4.5.3.4. Africa Genotyping Market by End-use

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1233

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of Genotyping.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Genotyping Market Size Worth USD 38.7 Billion By 2030 | CAGR 12.5%: Infinium Global Research here

News-ID: 3302402 • Views:

More Releases from Infinium Global Research LLP

Conveyor belt market outlook shows stable 4.17% CAGR over 2023-2030 forecast
Conveyor belt market outlook shows stable 4.17% CAGR over 2023-2030 forecast
Conveyor belts have become essential in industries ranging from manufacturing to food processing, playing a key role in automating material handling and improving operational efficiency. As the global economy continues to embrace automation, the conveyor belt market is experiencing significant growth. With a projected compound annual growth rate (CAGR) of 4.17% from 2023 to 2030, the market's value is expected to reach USD 5.74 billion by 2030, up from USD
Industrial automation market growth at 8.87% CAGR to drive USD 402 Bn by 2032
Industrial automation market growth at 8.87% CAGR to drive USD 402 Bn by 2032
The global industrial automation and equipment market is undergoing a transformative phase. As industries across various sectors face increasing pressure to enhance operational efficiency, productivity, and safety, automation is emerging as a vital solution. Industrial automation integrates advanced technologies like robotics, artificial intelligence (AI), and the Internet of Things (IoT) to reduce human intervention and streamline manufacturing processes. The equipment used in these automated operations plays an essential role in
Precision manufacturing tools market to reach USD 57 Bn by 2032, CAGR of 4% forecasted
Precision manufacturing tools market to reach USD 57 Bn by 2032, CAGR of 4% fore …
The global precision manufacturing tools market is witnessing significant growth, driven by increasing demand for high-quality and complex tools across multiple industries. These specialized tools, designed to achieve exceptional accuracy, are indispensable in manufacturing processes that require stringent tolerances and quality standards. As industries like aerospace, automotive, electronics, and medical devices expand, so too does the need for cutting-edge precision manufacturing tools that can deliver reliability, consistency, and efficiency. In 2023,
Heavy duty industrial tools market projected to reach USD 63 Bn by 2032 from USD 50 Bn
Heavy duty industrial tools market projected to reach USD 63 Bn by 2032 from USD …
The global market for heavy-duty industrial tools is experiencing steady growth, driven by technological advancements, industrial expansion, and rising demand across key sectors. As of 2023, the market size has surpassed USD 50 billion and is projected to expand at a compound annual growth rate (CAGR) of 2.62%, reaching USD 63 billion by 2032. The heavy-duty industrial tools market encompasses a wide range of tools designed to withstand tough conditions

All 5 Releases


More Releases for Genotyping

Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Genotyping Assay Market Size Growth Forecast: What to Expect by 2025? In recent times, the genotyping assay market has witnessed significant expansion. The market value is projected to rise from $33.98 billion in 2024 to $41.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.4%. Factors
The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Genotyping Market Size By 2025? The market size for genotyping has seen a swift expansion in the recent past. Its growth will continue to accelerate from $23.04 billion in 2024, reaching $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The
Top Factor Driving Genotyping Market Growth in 2025: The Surge In Cancer And Gen …
How Are the key drivers contributing to the expansion of the genotyping market? The escalating occurrence of cancer and genetic abnormalities is anticipated to drive the genotyping market's expansion. A myriad of diseases falling under the broad term 'cancer' can originate from virtually any tissue or organ in the body. Genetic disorders, meanwhile, are conditions that are completely or largely caused by deviations in the normal DNA sequence. Genotyping enables researchers
Genotyping Assay Market worth $37.1 billion by 2029
The major players in this market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US) The global genotyping assay market [https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr], valued at US$17.4 billion in 2023, is forecasted to grow at a robust CAGR of 13.8%, reaching US$19.4 billion in 2024 and an impressive US$37.1 billion by 2029. This growth is driven by
Genotyping Market Outlook and Major Regions' Development Status
The Genotyping Market report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Genotyping Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100001166?utm_source=OpenPR&utm_medium=10791 Key Players Analysis: Hoffmann-La Roche Ltd. Integrated DNA Technologies, Inc. QIAGEN MERCK KGaA Eurofins Genomics Thermo Fisher Scientific Inc BioTek Instruments, Inc. Xcelris Genomics TrimGen Corporation Illumina, Inc. The report covers key developments in the Genotyping
Single Nucleotide Polymorphisms Genotyping Market - Unraveling Genetic Codes, Un …
Newark, New Castle, USA - new report, titled Single Nucleotide Polymorphisms Genotyping Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Single Nucleotide Polymorphisms Genotyping market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Single Nucleotide Polymorphisms Genotyping market. The report offers